Baseball Legend Bernie Williams Goes to Bat for Liver Cancer
Eisai Inc. has recently teamed up with baseball legend and Latin Grammy-nominated musician Bernie Williams and advocacy partners Blue Faery and the Global Liver Institute to launch the One Liver to Love initiative to help raise awareness about liver cancer and the importance of adopting and maintaining healthy lifestyle choices to support liver health.
This campaign aims to help provide information, educational resources, advocacy support services, and a sense of community for anyone impacted by liver cancer. As part of the initiative, Williams shares his personal connection to, and passion for, liver health and taps into his baseball roots to highlight the four “bases” that can help support liver health—nutrition, exercise, sleep, and mental health. Liver disease is personal to Williams as it has affected his mother, grandfather, and uncle.
On behalf of Liver Cancer Awareness Month, Williams is joining the online conversation around liver health and liver cancer using the hashtag #OneLiverToLove on social media and we hope you and your constituents will also join the conversation and learn more about the initiative by visiting OneLiverToLove.com.
Eisai Inc. also invites you to join them on October 25th, for a Facebook Live event where you can hear from Bernie Williams and Dr. Mark Lewis, a medical oncologist and director of gastrointestinal oncology at Intermountain Healthcare, to learn more about the bases of liver health.
Click here to read the full press release – Eisai Partners with Baseball Legend to Help Support People Living with Liver Cancer
Recent News & Updates
In a move to lower health care costs for Americans, HHS announced earlier this year that it intends to take swift action to implement President Donald Trump’s Most Favored Nation (MFN) prescription drug pricing executive order.
An electronic health record (EHR) alert identifying patients with high-risk metastatic cancer entering the hospital, followed by a targeted set of interventions, resulted in significantly fewer 30-day readmissions and reduced length of stay (LOS) in a real-world study led by Michelle M. Chin, MS, from the University of Central Florida College of Medicine in Orlando, and colleagues. Findings were recently published in JCO Oncology Practice.
Patients need to communicate clearly with their health care provider. But that’s getting more difficult for those in the U.S. who don’t speak English.
For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers — allowing doctors to intervene when tumors may be easier to treat.
